These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2514343)

  • 1. [Estrogen dependent plasminogen activator in breast cancer cells; experimental and clinical studies].
    Yamashita J; Inada K; Matsuo S; Kawano I; Misumi A; Akagi M
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1932-8. PubMed ID: 2514343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-dependent plasminogen activator in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in vivo and in vitro.
    Yamashita J; Horiuchi S; Shigaki N; Fujino N; Akagi M
    Gan; 1984 Aug; 75(8):681-9. PubMed ID: 6436130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific stimulation by estradiol of tissue-type plasminogen activator production in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
    Yamashita J; Inada K; Yamashita S; Matsuo S; Nakashima Y; Ogawa M
    Horm Metab Res; 1992 Dec; 24(12):565-9. PubMed ID: 1478614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells.
    Yamashita J; Horiuchi S; Kimura M; Nishimura R; Akagi M
    Jpn J Cancer Res; 1986 Feb; 77(2):177-81. PubMed ID: 3082829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.
    Mira-y-Lopez R; Ossowski L
    Cancer Res; 1987 Jul; 47(13):3558-64. PubMed ID: 3107811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat.
    Ip C; Ip MM
    J Natl Cancer Inst; 1981 Feb; 66(2):291-5. PubMed ID: 6779045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone control of total plasminogen activator activity is specific to malignant DMBA-induced rat mammary tumours.
    Inada K; Yamashita J; Matsuo S; Nakashima Y; Yamashita S; Ogawa M
    Br J Cancer; 1992 Apr; 65(4):578-82. PubMed ID: 1562466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
    Jordan VC
    J Lab Clin Med; 1987 Mar; 109(3):267-77. PubMed ID: 3102656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxidase activity as a marker for estrogenicity: studies in uterus and mammary tumors.
    Levy J; Liel Y; Glick SM
    Isr J Med Sci; 1981; 17(9-10):970-5. PubMed ID: 7309486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal regulation of plasminogen activator and peroxidase activities in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and the rat uterus.
    Inada K; Yamashita J; Yoshimura T; Matsuo S; Nakashima Y; Yamashita S; Misumi A; Ogawa M
    Jpn J Surg; 1991 Mar; 21(2):249-52. PubMed ID: 1646904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
    Bradley CJ; Kledzik GS; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
    Butler WB; Kelsey WH; Goran N
    Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and purification of rat mammary tumor peroxidase.
    DeSombre ER; Lyttle CR
    Cancer Res; 1978 Nov; 38(11 Pt 2):4086-90. PubMed ID: 100215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
    Nomura S; Yoshida H; Kaneko Y
    In Vivo; 1990; 4(2):121-5. PubMed ID: 1966585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Bodwin JS; Clair T; Cho-Chung YS
    Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.